spacer
home > ict > summer 2018 > outsourcing evolution
PUBLICATIONS
International Clinical Trials

Outsourcing Evolution

Outsourcing in the pharmaceutical industry is a wellestablished practice, with a broad spectrum of outsourcing models deployed. These range from tactical staffing arrangements to complex, strategic, full-service models and from one-off contracts to preferred provider and strategic partnership agreements. Across this range of services and models, functional service provision (FSP) has emerged as a popular sourcing strategy, and enterprise-level partnership agreements between big CRO and pharma players are increasingly prevalent. Industry buyers have developed a deep understanding of different sourcing models. They are increasingly able to map the needs of their development portfolio to appropriate and varied sourcing strategies, and they select providers based on these needs. A CRO offering a full range of sourcing options is attractive as a singlesource provider to enable outsourcing managers to flex the model needed.

This article reviews some of the developments in outsourcing over time and more recent market trends. It also considers the evolution of FSP over the last 10 years and explores the benefits of enterprise-level partnerships and whether singlevendor sourcing is worth considering as a means of accessing greater efficiency and partnership with vendors.

Evolution of Outsourcing

Traditionally, two reasons existed for pharma companies to outsource to CROs: to access additional staffing or to get specific medical, scientific, or operational expertise for their trials. In the early days of outsourcing, essentially two approaches were available: a project-by-project, full-service outsourcing model − in which a pharma company delegated an entire project to a CRO to run − or contract staffing, where additional staff would be used to supplement the internal headcount as and when required.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Colin Stanley is President at ICON Functional ServicesICONs dedicated functional outsourcing service line. Colin has over 20 years of CRO industry experience and joined ICON as a Project Manager in 2001. Since then, he has held a range of roles of increasing responsibility, enabling him to develop extensive operational, functional, and geographic expertise. Colins roles at ICON have included Chief Operating Officer of DOCS; Vice President, Clinical Operations, Asia Pacific; Director of Clinical Operations, US; and Head of EU Data Management. He also led a global, cross-divisional, process improvement initiative within ICON. Colin holds a Bachelor of Science degree in biotechnology from Dublin City University, Ireland.
spacer
Colin Stanley
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Applikon Biotechnology launches fully customizable single-use bioreactor using 3D printing technology

Dutch-based upstream bioprocess equipment specialist Applikon Biotechnology B.V. (Applikon) has launched the single-use AppliFlex ST lab-scale bioreactor as a significant extension to its range of innovative bioreactor systems. AppliFlex ST is a fully customizable and scalable stirred tank single-use bioreactor that uses 3D printing technology to provide a head plate that is uniquely configured to each individual process, including custom impeller design, and different sample port connections.
More info >>

White Papers

PhlexEview: Transforming Costly Paper Processes into Value Driven Compliance

Phlexglobal Ltd

Looking at some of the challenges of traditional paper-based Trial Master Files (TMFs), and how they can be overcome with Phlexglobal's best in breed electronic TMF system, PhlexEview.
More info >>

 
Industry Events

SCOPE Europe Summit for Clinical Ops Executives Europe

17-18 September 2019, Barcelona, Spain

Building on the success of its long-running US-based counterpart, Summit for Clinical Trials Operations Executives Europe (SCOPE Europe) is a two-day event serving clinical innovation leaders, clin ops execs, functional heads, category managers, and those responsible for the planning and management of clinical trials in Europe and the Rest of the World. The event will feature opening and closing plenary keynote sessions, five conference tracks, interactive breakout discussion groups, and networking. It is an opportunity for leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, and academic research centers to come together to share best practices and discuss the new era of analytics-driven and patient-centric trials.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement